These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8728200)

  • 41. Cardiovascular risk factors in diabetic patients undergoing continuous ambulatory peritoneal dialysis.
    Babazono T; Miyamae M; Tomonaga O; Omori Y
    Adv Perit Dial; 1996; 12():120-5. PubMed ID: 8865885
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lipid parameters including lipoprotein (a) in patients undergoing CAPD and hemodialysis.
    Siamopoulos KC; Elisaf MS; Bairaktari HT; Pappas MB; Sferopoulos GD; Nikolakakis NG
    Perit Dial Int; 1995; 15(8):342-7. PubMed ID: 8785232
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nutritional markers during peritoneal dialysis: data from the 1998 Peritoneal Dialysis Core Indicators Study.
    Flanigan MJ; Frankenfield DL; Prowant BF; Bailie GR; Frederick PR; Rocco MV
    Perit Dial Int; 2001; 21(4):345-54. PubMed ID: 11587396
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Longitudinal changes in hemostatic factors in CAPD patients.
    Lee MS; Yang WS; Lee SK; Park JS; Chi HS; Kim SB
    Perit Dial Int; 2002; 22(4):518-20. PubMed ID: 12322826
    [No Abstract]   [Full Text] [Related]  

  • 45. Effects of 3-month amino acid dialysis compared to dextrose dialysis in children on continuous ambulatory peritoneal dialysis.
    Qamar IU; Levin L; Balfe JW; Balfe JA; Secker D; Zlotkin S
    Perit Dial Int; 1994; 14(1):34-41. PubMed ID: 8312411
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Two year experience with continuous ambulatory peritoneal dialysis.
    Wadgymar A; Wu GG; Fenton SS; Cattran DC; Allen AF; Page J
    Proc Clin Dial Transplant Forum; 1980; 10():109-13. PubMed ID: 6810338
    [No Abstract]   [Full Text] [Related]  

  • 47. Chronic intraperitoneal administration of amino acids does not improve the nutritional status of malnourished continuous ambulatory peritoneal dialysis patients.
    Dombros NV
    Perit Dial Int; 1993; 13 Suppl 2():S487-90. PubMed ID: 8399647
    [No Abstract]   [Full Text] [Related]  

  • 48. Nutritional management of dialysis patients: balancing among nutrient intake, dialysis dose, and nutritional status.
    Nakao T; Matsumoto H; Okada T; Kanazawa Y; Yoshino M; Nagaoka Y; Takeguchi F
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S133-6. PubMed ID: 12612970
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Whole body leucine turnover and nutritional status in continuous ambulatory peritoneal dialysis.
    Goodship TH; Lloyd S; Clague MB; Bartlett K; Ward MK; Wilkinson R
    Clin Sci (Lond); 1987 Nov; 73(5):463-9. PubMed ID: 3677555
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The influence of continuous ambulatory peritoneal dialysis on plasma lipoproteins.
    Breckenridge WC; Roncari DA; Khanna R; Oreopoulos DG
    Atherosclerosis; 1982 Dec; 45(3):249-58. PubMed ID: 6961923
    [No Abstract]   [Full Text] [Related]  

  • 51. Relationship between adequacy of dialysis and nutritional status, and their impact on patient survival on CAPD in Hong Kong.
    Lo WK; Tong KL; Li CS; Chan TM; Wong AK; Ho YW; Cheung KO; Kwan TH; Wong KS; Ng FS; Cheng IK
    Perit Dial Int; 2001; 21(5):441-7. PubMed ID: 11757826
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Nutritional status of children treated with continuous ambulatory peritoneal dialysis and ambulatory peritoneal dialysis].
    Makulska I; Zwolińska D; Kiliś-Pstrusińska K; Magier K
    Pol Merkur Lekarski; 2001 Apr; 10(58):219-23. PubMed ID: 11434160
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessment of dialysis adequacy: beyond urea kinetic measurements.
    Rees L
    Pediatr Nephrol; 2019 Jan; 34(1):61-69. PubMed ID: 29582148
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Independent effects of residual renal function and dialysis adequacy on nutritional status and patient outcome in continuous ambulatory peritoneal dialysis.
    Szeto CC; Lai KN; Wong TY; Law MC; Leung CB; Yu AW; Li PK
    Am J Kidney Dis; 1999 Dec; 34(6):1056-64. PubMed ID: 10585315
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lipoprotein(a) levels in chronic renal disease states, dialysis and transplantation.
    Irish AB; Simons LA; Savdie E; Hayes JM; Simons J
    Aust N Z J Med; 1992 Jun; 22(3):243-8. PubMed ID: 1386727
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of peritoneal dialysis solution type on serum lipid levels in end-stage renal disease.
    Kanbay M; Bavbek N; Delibasi T; Koca C; Kaya A; Altay M; Akcay A; Duranay M; Yigitoglu R
    Ren Fail; 2007; 29(3):309-13. PubMed ID: 17497445
    [TBL] [Abstract][Full Text] [Related]  

  • 57. We Use Kt/V Urea as a Measure of Adequacy of Peritoneal Dialysis.
    Bargman JM
    Semin Dial; 2016 Jul; 29(4):258-9. PubMed ID: 27081745
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cross sectional assessment of weekly urea and creatinine clearances and indices of nutrition in continuous ambulatory peritoneal dialysis patients.
    Nolph KD; Moore HL; Prowant B; Meyer M; Twardowski ZJ; Khanna R; Ponferrada L; Keshaviah P
    Perit Dial Int; 1993; 13(3):178-83. PubMed ID: 8369345
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Dialysis capacity of peritoneum in CAPD].
    Yamamoto Y
    Nihon Jinzo Gakkai Shi; 1986 Aug; 28(8):1119-28. PubMed ID: 3807044
    [No Abstract]   [Full Text] [Related]  

  • 60. IL-18 is involved in vascular injury in end-stage renal disease patients.
    Porazko T; Kúzniar J; Kusztal M; Kúzniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
    Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.